Hong Kong stock anomaly | Three Clover Biotech-B (02197.HK) surged over 38% in the last trading session, recently launching Phase I clinical trials for a respiratory tract combination vaccine candidate.

According to the Securities Times app, Trifolium Biologicals-B (02197.HK) surged more than 38% in the last trading session, up 35.21% at the time of writing, with a price of HKD 0.48 and a trading volume of 15.1574 million Hong Kong dollars.